Postoperative Adjuvant TACE for Patients of Hepatocellular Carcinoma in AJCC Stage I: Friend or Foe? A Propensity Score Analysis

Oncotarget - United States
doi 10.18632/oncotarget.15793
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Optimal Postoperative Adjuvant Treatment Strategy for HBV-related Hepatocellular Carcinoma With Microvascular Invasion: A Propensity Score Analysis

OncoTargets and Therapy
OncologyPharmacology
2019English

CD24 as a Novel Predictive Biomarker in Patients With Hepatocellular Carcinoma: Friend or Foe?

Journal of Investigative Surgery
Surgery
2018English

Abstract No. 517 Conventional vs. Drug-Eluting Beads TACE for Hepatocellular Carcinoma: A Propensity Score–weighted Comparison

Journal of Vascular and Interventional Radiology
Nuclear MedicineRadiologyCardiologyCardiovascular MedicineImagingMedicine
2018English

Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-Ii Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis

Cancer Research and Treatment
Cancer ResearchOncology
2014English

Friend or Foe?

Archives of Internal Medicine
2000English

Potassium Binders in Hemodialysis Patients: A Friend or Foe?

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2013English

Ectomycorrhiza, Friend or Foe?

Ecosystems
Environmental ChemistryEvolutionEcologySystematicsBehavior
2019English

Azathioprine: Friend or Foe?

British Journal of Dermatology
DermatologyMedicine
2019English

Cramster: Friend or Foe?

Physics Teacher
EducationPhysicsAstronomy
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy